{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "The Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) is a pair of randomized trials"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "a pair of randomized trials assessing the relative efficacy of carotid revascularization"
      },
      "Participants": {
        "score": 1,
        "evidence": "patients with asymptomatic high-grade atherosclerotic stenosis"
      },
      "Intervention": {
        "score": 2,
        "evidence": "One of the trials assesses IMM with or without carotid artery stenting (CAS)."
      },
      "Objective": {
        "score": 1,
        "evidence": "This analysis describes the protocol-driven approach to credentialing of CAS interventionists for CREST-2 and its outcomes."
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "approval increased to 46% (153/334) after submission of new cases with added training and rereview."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 8,
    "max_score": 25
  },
  "model": "gpt-4o"
}